Send feedback

EPO p.Ser18=

c.54G>A · rs73409072 · VCV716882

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
rare (popmax 0.857%, afr)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.6GERP -1.7, phastCons 0.98
Overall
CADD7.475PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.857% African / African-American · 643/75,026 alleles
Filtering AF 0.802% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.78%
Overall 0.0442% 713/1,613,878 alleles · rare
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.857% 117
Admixed American 0.04% 2,500
Remaining individualsnot grpmax-eligible 0.0352% 2,841
South Asian 0.0132% 7,590
Finnishnot grpmax-eligible 0.00313% 31,900
East Asian 0.00223% 44,878
European (non-Finnish) 0.000763% 131,113

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EPO
Protein
p.Ser18=
Coding
c.54G>A
MANE Select
NM_003254 · reported on NM_000799
dbSNP
rs73409072
Type
single nucleotide variant
Location
chr7:100721598 (GRCh38)
Structure
AlphaFold pLDDT 90.09 · 13 PDB
Full EPO gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/epo-p-ser18 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown